Monday, September 28, 2015

Opdivo (nivolumab) Demonstrates Long Term Survival Benefit in Patients with Previously Treated Non-Squamous Non-Small Cell Lung Cancer in CheckMate -057

… expression. Rates of PD-L1 expressing tumors were balanced between groups. PD-L1 … cancer results in more deaths worldwide than colorectal, breast and prostate cancers combined. Non-small cell lung cancer is one of …

No comments:

Post a Comment